Theriva Biologics TOVX
NYSE TOVX
$0.23 +0.01 (+2.40%)
As of: Oct 1, 2026 · 3:56 PM EDT

Theriva Biologics (TOVX) Non-Current Deferred Tax Liability (2022 - 2023)

Updated

Theriva Biologics (TOVX) recorded Non-Current Deferred Tax Liability of $413,000 in Q3 2023, down 79.2% from $1.98 million a year earlier and down 56.6% from the prior quarter.

Analysis

Theriva Biologics (TOVX) Non-Current Deferred Tax Liability (2022 - 2023) Analysis & Trends

At the end of FY2022, Theriva Biologics reported Non-Current Deferred Tax Liability of $1.62 million.

  • On a year-over-year basis, Non-Current Deferred Tax Liability has declined for three consecutive quarters.
  • Per Business Quant, the preceding three quarters came in at $952,000 (Q2 2023), $1.31 million (Q1 2023) and $1.62 million (Q4 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Theriva Biologics 10.56 Mn 10.56 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 413,000.00
Jun 30, 2023 952,000.00
Mar 31, 2023 1.31 Mn
Dec 31, 2022 1.62 Mn
Sep 30, 2022 1.98 Mn
Jun 30, 2022 2.29 Mn
Mar 31, 2022 3.73 Mn
API Access

Theriva Biologics Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=TOVX&period=max&api_key=YOUR_API_KEY